Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pneumococcal vaccination

R M Williams1

  • 1Pacific Coast Primary Care, Daly City, California 94015, USA.

Lippincott'S Primary Care Practice
|January 12, 1999
PubMed
Summary
This summary is machine-generated.

Community-acquired pneumonia (CAP) causes significant mortality and healthcare costs. Vaccination against Streptococcus pneumoniae can prevent many deaths and reduce economic burden, especially in high-risk populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Prospective Phase I/II Study of Docetaxel, Cisplatin and Continuous Capecitabine in Advanced Oesophago-Gastric Cancer (NWCOG-3).

Clinical oncology (Royal College of Radiologists (Great Britain))·2018
Same author

Development of a low-level <sup>39</sup>Ar calibration standard - Analysis by absolute gas counting measurements augmented with simulation.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2017
Same author

First results of a simultaneous measurement of tritium and (14)C in an ultra-low-background proportional counter for environmental sources of methane.

Journal of environmental radioactivity·2016
Same author

Shielding concepts for low-background proportional counter arrays in surface laboratories.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2016
Same author

Development of a low-level (37)Ar calibration standard.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2015
Same author

Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.

Natural product reports·2014
Same journal

Cold or flu.

Lippincott's primary care practice·2002
Same journal

Ear wax.

Lippincott's primary care practice·2002
Same journal

Nasal sprays and irrigations.

Lippincott's primary care practice·2002
Same journal

Acute laryngitis.

Lippincott's primary care practice·2002
Same journal

Acute otitis externa.

Lippincott's primary care practice·2002
Same journal

Young boy presenting with swollen glands and sore throat.

Lippincott's primary care practice·2002
See all related articles

Area of Science:

  • Infectious Diseases
  • Public Health
  • Vaccinology

Background:

  • Streptococcus pneumoniae causes community-acquired pneumonia (CAP), leading to 40,000 deaths annually.
  • CAP is the leading cause of infection-related mortality, with 50% of deaths preventable by pneumococcal vaccination.
  • Despite high prevention rates, only 28% of individuals aged 65 and older receive the vaccine.

Purpose of the Study:

  • To highlight the preventable mortality and economic burden associated with Streptococcus pneumoniae CAP.
  • To emphasize the underutilization of the pneumococcal vaccine in older adults.
  • To advocate for improved immunization strategies in high-risk populations.

Main Methods:

  • Review of existing literature on Streptococcus pneumoniae CAP epidemiology.

Related Experiment Videos

  • Analysis of vaccine efficacy and current vaccination rates in elderly populations.
  • Discussion of cost-effectiveness of CAP prevention through vaccination.

    • Main Results:

    • Pneumococcal vaccination can prevent 56-81% of invasive pneumococcal infections in immunocompetent adults.
    • Treating CAP costs over $23 billion annually in the US, with over $3.5 billion for Medicare patients.
    • Low vaccination rates in high-risk groups contribute to preventable morbidity, mortality, and healthcare expenditures.

    Conclusions:

    • Immunizing high-risk patients for CAP can significantly improve health outcomes and reduce mortality.
    • Increased pneumococcal vaccination rates are crucial for public health and reducing healthcare costs.
    • Guidelines for identifying high-risk groups and vaccination recommendations are essential for effective CAP prevention.